Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Badio, M; Lhomme, E; Kieh, M; Beavogui, AH; Kennedy, SB; Doumbia, S; Leigh, B; Sow, SO; Diallo, A; Fusco, D; +16 more...Kirchoff, M; Termote, M; Vatrinet, R; Wentworth, D; Esperou, H; Lane, HC; Pierson, J; Watson-Jones, D
; Roy, C; D'Ortenzio, E; Greenwood, B
; Chêne, G; Richer, L; Neaton, JD; Yazdanpanah, Y; PREVAC study team and
PREVAC study team;
(2021)
Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Trials, 22 (1).
583-.
ISSN 1745-6215
DOI: 10.1186/s13063-021-05572-3
Following the publication of the original article [1], we were notified of an error in the affiliation of 3 authors of the article: Celine Roy, Laura Richert and Genevieve Chene. Their affiliation was initially mentioned as: “Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia” However, their correct affiliation is: Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.tp.
Item Type | Article |
---|---|
Elements ID | 165979 |
Date Deposited | 09 Nov 2021 11:49 |
ORCID: https://orcid.org/0000-0001-6247-1746
ORCID: https://orcid.org/0000-0001-5725-9118